Brain imaging software developer CorTechs Labs has received the CE Mark to distribute its NeuroQuant application in Europe.
NeuroQuant also has clearance from the U.S. Food and Drug Administration (FDA) to provide data analysis and detection of atrophy in the human brain using automated MRI postprocessing capabilities.
The software is designed to help neurologists, radiologists, and clinical researchers quantify the volumes of specific brain structures for conditions such as Alzheimer's disease, traumatic brain injury, multiple sclerosis, and epilepsy.
